Science Explorer Back to mapMap
Discussion
Company · Craiova · Romania

Oncolab (Romania)

Research works
4
▼ 8% vs 2018-21
Citations
41
9.7 per fractional work
Top-10% rate
3.0%
all institutions 10.0%
Open access
73%
world 40%
International
31%
world 18%

Not ranked overall: Oncolab (Romania) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Oncolab (Romania) work in?

In all years, 66% of research at Oncolab (Romania) is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (66%), Engineering (17%), Biochemistry, Genetics and Molecular Biology (15%). It does 1.4× the world's share of Health Sciences.

Life Sciences17%Physical Sciences17%Health Sciences66%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine365.9%
    1. Biochemistry, Genetics and Molecular Biology114.6%
    2. Immunology and Microbiology02.4%
    1. Engineering117.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Oncolab (Romania)?

The most cited paper from Oncolab (Romania) is "Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial" (Salomon Marcello Stemmer et al., 2021), with 49 citations. Next come "An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus" (48) and "Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study" (4).

Most cited papers
#PaperReleasedCitations
1 Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial Salomon Marcello Stemmer et al. · Cancers Open access 7 Jan 2021 49
2 An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus Flavia Cristina Vasile, Agnesa Preda, Adela Gabriela Ștefan et al. · Journal of Diabetes Research Open access 18 Nov 2021 48
3 Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study Gilles Freyer, Noelia Martínez-Jáñez, Bożena Kukiełka-Budny et al. · The Breast Open access 9 Feb 2024 4
4 Artificial intelligence in contrast enhanced ultrasound: A new era for liver lesion assessment Adriana Ciocâlteu, Marinela Cristiana Urhuț, Costin Teodor Streba et al. · World Journal of Gastroenterology Open access 13 Nov 2025 2
5 Survival and Treatment Outcomes in Gastric Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis Daniel Genel Sur, Adina Turcu-Ştiolică, Emil Moraru et al. · Cancers ReviewOpen access 12 Nov 2024 2
All 15 most cited papers, with filters and sorting

Which research topics does Oncolab (Romania) publish most on?

By volume in 2022-now: Lung Cancer Research Studies, Microbial Inactivation Methods, Salivary Gland Tumors Diagnosis and Treatment and Veterinary Oncology Research.

  1. 1 Lung Cancer Research Studies Oncology 0 works
  2. 2 Microbial Inactivation Methods Biotechnology 0 works
  3. 3 Salivary Gland Tumors Diagnosis and Treatment Surgery 0 works
  4. 4 Veterinary Oncology Research Pulmonary and Respiratory Medicine 0 works
  5. 5 Ultrasound and Hyperthermia Applications Biomedical Engineering 0 works
  6. 6 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  8. 8 Ultrasound Imaging and Elastography Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  10. 10 Advanced Biosensing Techniques and Applications Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available72.8%not open27.2%

World: 40% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 18% is written across borders.

How has Oncolab (Romania)'s research output changed?

Output in 2022-2025 was 8% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Craiova

All research institutions in Craiova

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Oncolab (Romania). Posts are plain text and can be reported.